Summary

CRO, biotechnology, research and development, consulting, contracting, cancer, CNS, central nervous system, brain cancer, neuroinflammation, 3D spheroid, organoid, efficacy, drug testing, immunohistochemistry, tissue culture, oncology, Biosafety level 2, BSL2

Description

Our mission at Biotect is to facilitate the translation of cancer and CNS disease interventions with improved predictability of clinical outcomes. We do this by offering in vitro and some in vivo assays to characterize and better understand drug products. In-lab services include both traditional 2D and spheroid 3D cell culture using customized cancer cell lines, neurons, or glial cells. Core assays include: drug efficacy, ICC, tumor penetration, and live/dead cell counts by flow cytometry. Neuroinflammation and neural co-culture models are under development. To accomplish this work, we partner together with drug sponsors to protect patients from life-threatening diseases.

Special details

Specialized equipment include 2 biological safety cabinets, 3 incubators, 2 low speed centrifuges, and an ultralow freezer, analytical balance, and inverted microscope with fluorescence and high resolution camera, gel documentation system, luminometer, and plate reader. Through Core facilities at the local university (Colorado State University) we pay for use of the flow cytometer, qPCR system, and high powered microscopes.

Profile

  • Incorporated in
    Colorado
  • Established since
    2018
  • Main/Branch
    Branch

Address

Contact